Migdal Insurance & Financial Holdings Ltd. Cor Medix Inc. Transaction History

Migdal Insurance & Financial Holdings Ltd.

$6.18 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$3.83 - $6.24 $4,496 - $7,325	-1,174 Closed	0 $0
Q4 2021 Feb 02, 2022	SELL	$4.47 - $5.56 $3,164 - $3,936	-708 Reduced 37.62%	1,174 $6,000
Q3 2021 Nov 16, 2021	BUY	$4.46 - $7.11 $8,393 - $13,381	1,882 New	1,882 $9,000

Others Institutions Holding CRMD

# of Institutions

105

Shares Held

17.4M

Call Options Held

134K

Put Options Held

441K

Black Rock Inc. New York, NY

3.55M
Shares

$28.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.07M
Shares

$24.9 Million
0.0% of portfolio
Paul Singer Elliott Investment Management L.P. | West Palm Beach, Fl

1.55M
Shares

$12.6 Million
0.07% of portfolio
Geode Capital Management, LLC Boston, MA

1.28M
Shares

$10.4 Million
0.0% of portfolio
State Street Corp Boston, MA

1.23M
Shares

$9.93 Million
0.0% of portfolio

View Full List

About CorMedix Inc.

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $334M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

More about CRMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Migdal Insurance & Financial Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Migdal Insurance & Financial Holdings Ltd. with notifications on news.

Account